Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,500 | 1 | 93.8% |
| Food and Beverage | $164.55 | 11 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Provepharm Inc. | $2,500 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $93.13 | 7 | $0 (2019) |
| Ambu Inc. | $25.21 | 1 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $19.47 | 1 | $0 (2017) |
| Intercept Pharmaceuticals, Inc. | $13.46 | 1 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $13.28 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38.49 | 2 | Ambu Inc. ($25.21) |
| 2022 | $2,500 | 1 | Provepharm Inc. ($2,500) |
| 2019 | $26.66 | 2 | Merck Sharp & Dohme Corporation ($26.66) |
| 2018 | $53.13 | 4 | Merck Sharp & Dohme Corporation ($39.67) |
| 2017 | $46.27 | 3 | Merck Sharp & Dohme Corporation ($26.80) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Rare Disease | ||||||
| 03/27/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $25.21 | General |
| 10/22/2022 | Provepharm Inc. | BLUDIGO (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: MARKER DYE | ||||||
| 05/21/2019 | Merck Sharp & Dohme Corporation | BRIDION (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2019 | Merck Sharp & Dohme Corporation | BRIDION (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2018 | Merck Sharp & Dohme Corporation | BRIDION (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2018 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 02/21/2018 | Merck Sharp & Dohme Corporation | BRIDION (Drug), ENTEREG | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/27/2017 | Merck Sharp & Dohme Corporation | BRIDION (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2017 | Merck Sharp & Dohme Corporation | BRIDION (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2017 | BOSTON SCIENTIFIC CORPORATION | ACCOLADE (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: BRADY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 31 | 31 | $21,044 | $2,749 |
| 2020 | 1 | 17 | 17 | $35,568 | $2,109 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 19 | 19 | $11,500 | $1,394 | 12.1% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 12 | 12 | $9,544 | $1,355 | 14.2% |
| 01922 | Anesthesia for x-ray or radiation therapy | Facility | 2020 | 17 | 17 | $35,568 | $2,109 | 5.9% |
About Dr. Ryan Fields, M.D
Dr. Ryan Fields, M.D is a Pediatric Anesthesiology healthcare provider based in Neptune, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427092386.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Fields, M.D has received a total of $2,665 in payments from pharmaceutical and medical device companies, with $38.49 received in 2024. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($2,500).
As a Medicare-enrolled provider, Fields has provided services to 48 Medicare beneficiaries, totaling 48 services with total Medicare billing of $4,858. Data is available for 2 years (2020–2022), covering 3 distinct procedure/service records.
Practice Information
- Specialty Pediatric Anesthesiology
- Other Specialties Anesthesiology
- Location Neptune, NJ
- Active Since 06/15/2006
- Last Updated 04/26/2024
- Taxonomy Code 207LP3000X
- Entity Type Individual
- NPI Number 1427092386
Products in Payments
- BLUDIGO (Drug) $2,500
- BRIDION (Drug) $82.34
- ACCOLADE (Device) $19.47
- OCALIVA (Drug) $13.46
- ULTOMIRIS (Biological) $13.28
- DIFICID (Drug) $10.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.